This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Calcium and magnesium can be taken together at typical multivitamin or supplemental doses without meaningful interaction concerns. The most relevant absorption interaction in this mineral family is calcium reducing non-haem iron absorption (Hallberg 1991), not calcium-magnesium. For magnesium specifically, high-dose calcium (above 500 mg in a single dose) may reduce magnesium absorption modestly. At moderate doses (calcium below 500 mg, magnesium 200-400 mg), taking them together is fine; at higher doses, splitting across different meals is reasonable.
The much better-documented interaction in the same family is calcium-on-iron absorption: Hallberg 1991 (Am J Clin Nutr 53(1):112-119, PMID 1984335) showed 165-600 mg calcium dose-dependently reduced non-haem iron absorption by 50-60%. Iron-magnesium interaction at supplemental doses is also documented (Rossander-Hultén 1991, Am J Clin Nutr 54(1):152-156, PMID 2058577) but does not directly affect calcium-magnesium dosing.
Practical dose thresholds: below 500 mg calcium and 200-400 mg magnesium taken together at the same time, minimal practical interaction. Above 500 mg calcium and 400 mg magnesium taken together, separating by 1-2 hours or across different meals is reasonable. Patients on supplemental calcium for osteoporosis (typically 500-1200 mg/day) plus magnesium supplementation: split across multiple meals.
Combination calcium-magnesium products (often at 2:1 calcium:magnesium ratio) are widely sold. The historical justification was the natural ratio of these minerals in food. Evidence that set-ratio combination supplementation is superior to addressing each mineral based on individual status is weak. Form selection for magnesium follows separate evidence by clinical application (see magnesium form comparison entry).
Calcium citrate is less acid-dependent and can be taken with or without food. A practical default schedule: calcium with breakfast or lunch, magnesium at bedtime. This is about supporting the effects of each rather than avoiding interaction. Bisphosphonate timing requires at least 2 hours separation from any divalent cation supplement (calcium, magnesium, iron); ideally 4 hours.
Chronic kidney disease (eGFR below 30): both calcium and magnesium clearance is impaired; supplementation requires supervision. Hyperparathyroidism: calcium handling is dysregulated; supplementation requires clinical guidance. Diuretic-induced magnesium loss can change the calculus on supplementation. Above-UL magnesium supplementation can cause diarrhoea and, in renal impairment, more serious electrolyte disturbance.
Chronic kidney disease (eGFR below 30): both calcium and magnesium clearance is impaired; supplementation should be supervised. Hyperparathyroidism: calcium handling is dysregulated; supplementation requires clinical guidance. Pregnancy: routine antenatal screening covers calcium adequacy; magnesium status is not routinely screened but RDA is similar to non-pregnant values. Older adults: higher calcium needs (1200 mg/day for women 51+); reduced ability to handle high mineral loads.
Loop diuretics (furosemide) and thiazide diuretics affect magnesium balance differently: loop diuretics increase urinary magnesium loss (depletion risk); thiazides have variable effects. PPIs reduce magnesium absorption with chronic use (FDA warning 2011). Standard mineral interactions also apply between calcium, iron, and zinc at high single doses.
| Interaction | Issue | Guidance | Citation |
|---|---|---|---|
| Calcium or magnesium and iron | Calcium reduces non-haem iron absorption | Separate iron supplements from calcium- or magnesium-containing meals by around 2 hours | NIH ODS — Calcium Fact Sheet; NIH ODS — Iron Fact Sheet |
| Calcium or magnesium and zinc | High single doses of divalent cations compete for absorption | Separate single doses of zinc from calcium or magnesium by around 1-2 hours | NIH ODS — Magnesium Fact Sheet; NIH ODS — Zinc Fact Sheet |
Mah and Pitre 2021 SR/MA covers magnesium and sleep onset latency in older adults with insomnia. Abbasi 2012 RCT in older adults with insomnia is the principal sleep-related magnesium study. SACN provides UK population reference values. The cardiovascular safety debate around high-dose calcium supplementation has been characterised in multiple meta-analyses with mixed conclusions; specific clinical decisions follow individual context.
Many adults have higher likelihood of magnesium inadequacy than calcium inadequacy at typical Western intake patterns. Assessing dietary intake and clinical status before assuming a combination product is appropriate is reasonable. Where a set-ratio combination product is in use, the dose of each mineral should still meet individual need, not the ratio. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.
Claim: calcium and magnesium block each other's absorption significantly. The evidence for direct calcium-on-magnesium absorption inhibition is weaker than the marketing suggests; effects are small at typical doses. The much better-documented interaction is calcium-on-iron absorption (Hallberg 1991). Combination calcium-magnesium products are widely sold but the evidence base for the set-ratio approach is limited.
This entry is relevant for the following groups, conditions, and medication contexts: